{{Rsnum
|rsid=7651446
|Gene=TIPARP
|Chromosome=3
|position=156689208
|Orientation=plus
|GMAF=0.06061
|Gene_s=TIPARP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 90.3 | 9.7 | 0.0
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 64.4 | 31.5 | 4.1
| ASW | 59.6 | 35.1 | 5.3
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 81.7 | 18.3 | 0.0
| MEX | 91.2 | 8.8 | 0.0
| MKK | 80.6 | 18.7 | 0.6
| TSI | 95.1 | 4.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535730
  |Trait=Ovarian cancer
  |Title=GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
  |RiskAllele=
  |Pval=2E-29
  |OR=1.44
  |ORtxt=[1.35-1.54]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}